Identifying the efficacy of the plant-origin flavonoid rutin in 2 doses (250mg and 500mg) and 2 delivery forms (yoghurt and capsules)

Not Applicable

• Conditions: diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12618000630213
• Lead Sponsor: niversity of Auckland Research Office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-20
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

•Aged between 18-65 years
•BMI between 23-35 kg/m2
•Fasting plasma glucose (FPG) < 5.6 mmol/L
•Healthy, as per self-report

Exclusion Criteria

•Type 2 or type 1 diabetes
•Other significant disease including cardiovascular disease, pancreatic disease or cancer; or digestive disease including inflammatory bowel syndrome/disease (IBS/D), ulcerative colitis (UC), Crohn's disease
•Medications controlling glycaemia
•Current use of rutin or quercetin supplements
•Recent body weight loss/gain >10% within previous 3 months or taking part in an active diet program; or current medications for weight loss
•Dislike or unwilling to consume food items included in the study, or hypersensitivities or allergies to these foods, i.e. rutin allergy, lactose intolerant, does not consume yogurt
•Pregnant or breastfeeding women
•Unwilling/unable to comply with study protocol
•Concurrent participation in other clinical studies, or such participation within the last 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified